Intergenerational Transmission of Terror

The recruitment status of this study is unknown because the information has not been verified recently.

Verified November 2006 by Hadassah Medical Organization.
Recruitment status was Not yet recruiting

Sponsor:

Information provided by:

Hadassah Medical Organization

ClinicalTrials.gov Identifier:

NCT00320437

First received: April 30, 2006

Last updated: November 29, 2006

Last verified: November 2006

History of Changes

Purpose

Our aim is examine avenues by which mothers can transmit their trauma to their children.

Condition	Phase
Anxiety Trauma Stress Disorders	Phase 1


Study Type:	Observational
Study Design:	Observational Model: Defined Population Time Perspective: Longitudinal Time Perspective: Prospective
Official Title:	The Intergenerational Transmission of Trauma From Terror: A Developmental Perspective

Resource links provided by NLM:

MedlinePlus related topics: Anxiety Wounds and Injuries

U.S. FDA Resources

Further study details as provided by Hadassah Medical Organization:


Estimated Enrollment:	300
Study Start Date:	May 2007
Estimated Study Completion Date:	December 2008

Detailed Description:

The goal of the study is to test for genetic bases and Gene x Environment interactions on the development of difficulties, particularly stress disorders, in young children whose mother were exposed to terror before they were born.

Eligibility


Ages Eligible for Study:	Child, Adult, Senior
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Pregnant women who were exposed to terror in the last 5 years
Matched Controls

Exclusion Criteria:

Does not speak Hebrew or English

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00320437

Contacts


Contact: David Mankuta, MD MHA	00 972 507 874788	mankuta@yahoo.com
Contact: Hadas Lemberg, PhD	00 972 2 677572	Ihadas@hadassah.org.il

Locations


Israel
Hadassah University Hospital	Not yet recruiting
Jerusalem, Ein Kerem, Israel, 91120
Contact: David Mankuta, MD MHA 00 972 507 874788 mankuta@yahoo.com
Contact: Hadas Lemberg, PhD 00 972 2 6776095 Ihadas@hadassah.org.il
Principal Investigator: David Mankuta, MD MHA

Sponsors and Collaborators

Hadassah Medical Organization

Investigators


Principal Investigator:	Steven Faraone, PhD	State University of New York - Upstate Medical University

More Information


ClinicalTrials.gov Identifier:	NCT00320437 History of Changes
Other Study ID Numbers:	terror HMO-CTIL
Study First Received:	April 30, 2006
Last Updated:	November 29, 2006
Health Authority:	Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Hadassah Medical Organization:


trauma anxiety antenatal	mothers children Gene x Environment Interaction

Additional relevant MeSH terms:


Wounds and Injuries Stress Disorders, Traumatic Trauma and Stressor Related Disorders Mental Disorders

ClinicalTrials.gov processed this record on September 26, 2016

To Top